| scholarly article | Q13442814 |
| P50 | author | Joe Yeong | Q57368883 |
| P2093 | author name string | Puay Hoon Tan | |
| Hui Hua Li | |||
| Jabed Iqbal | |||
| Ana Richelia Jara-Lazaro | |||
| Aye Aye Thike | |||
| Nirmala Pathmanathan | |||
| Chee Leong Cheng | |||
| Jeffrey Chun Tatt Lim | |||
| Jane Sie Yong Tan | |||
| Valerie Cui Yun Koh | |||
| Timothy Kwang Yong Tay | |||
| Zi Long Chow | |||
| Adeline Shi Hui Sng | |||
| Heng Seow Ye | |||
| P2860 | cites work | Digital image analysis outperforms manual biomarker assessment in breast cancer. | Q39967968 |
| Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer | Q40061893 | ||
| The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer. | Q40299367 | ||
| Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma | Q40626929 | ||
| St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods | Q48511251 | ||
| Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer. | Q54519817 | ||
| Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis | Q68243639 | ||
| Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial | Q78359789 | ||
| Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 | Q30543788 | ||
| Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index | Q33717341 | ||
| A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue | Q33739487 | ||
| The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes | Q34171441 | ||
| Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays | Q34466187 | ||
| Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies | Q34775344 | ||
| Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 | Q35130819 | ||
| Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study | Q35692692 | ||
| Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. | Q35889626 | ||
| Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma | Q36295045 | ||
| Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer | Q36393082 | ||
| Ki67 immunostaining in primary breast cancer: pathological and clinical associations | Q36466510 | ||
| Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer | Q36494250 | ||
| Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry | Q36892788 | ||
| Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up | Q36922535 | ||
| Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups | Q37350137 | ||
| Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer | Q38404863 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11619-11630 | |
| P577 | publication date | 2018-02-05 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer | |
| P478 | volume | 9 |
| Q92010574 | Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy | cites work | P2860 |
Search more.